Liposome Drug Delivery Market Analysis

  • Report ID: 4073
  • Published Date: Dec 06, 2024
  • Report Format: PDF, PPT
  1. Market Definition
    1. Definition
    2. Market Segmentation
  2. Assumptions and Acronyms
  3. Research Methodology
    1. Research Process
    2. Primary Research
    3. Secondary Research
  4. Executive Summary – Global Liposome Drug Delivery Market
  5. Market Dynamics
    1. Drivers
    2. Challenges
    3. Trends
    4. Opportunities
  6. Pipeline Analysis
  7. Clinically Marketed Liposome Drugs
  8. Regulatory Scenario Assessment
  9. Analysis on Lipid Nanoparticles
  10. Competitive Landscape
    1. Market Share Analysis, 2021
    2. Company Profiles
      1. Pharmaceutical Formulation Manufacturers
        1. Spectrum Pharmaceuticals, Inc.
        2. Gilead Sciences, Inc.
        3. Celsion Corporation
        4. Ipsen Pharma
        5. Pacira Pharmaceuticals, Inc.
        6. Novartis AG
        7. CordenPharma International
        8. FUJIFILM Toyama Chemical Co., Ltd.
        9. Takeda Pharmaceutical Company Limited
        10. Johnson & Johnson Services, Inc.
        11. Astellas Pharma Inc.
        12. Elan Pharmaceuticals (Perrigo Company plc)
        13. Merrimack Pharmaceuticals, Inc.
        14. Janssen Pharmaceuticals, Inc.
      2. Raw Material Manufacturers
        1. NIPPON FINE CHEMICAL CO., LTD.
        2. Sonic Biochem Extractions Pvt. Ltd.
        3. Croda International Plc
        4. Lipoid GmbH
        5. Hashimoto Electronic Industry Co., LTD
  11. Global Liposome Drug Delivery Market
    1. Market Overview
    2. Market Size (2023-2036)
    3. Market Segmentation by:
      1. Product
        1. Liposomal Doxorubicin, 2023-2036F (USD Million)
        2. Liposomal Paclitaxel, 2023-2036F (USD Million)
        3. Liposomal Amphotericin, 2023-2036F (USD Million)
        4. Others, 2023-2036F (USD Million)
      2. Technology
        1. Stealth Liposome Technology, 2023-2036F (USD Million)
        2. Non-PEGylated Liposome Technology, 2023-2036F (USD Million)
        3. DepoFoam Liposome Technology, 2023-2036F (USD Million)
      3. Application
        1. Fungal Diseases, 2023-2036F (USD Million)
        2. Pain Management, 2023-2036F (USD Million)
        3. Cancer Therapy, 2023-2036F (USD Million)
        4. Viral Vaccines, 2023-2036F (USD Million)
        5. Photodynamic Therapy, 2023-2036F (USD Million)
        6. Others, 2023-2036F (USD Million)
      4. Region
        1. North America, 2023-2036F (USD Million)
        2. Europe, 2023-2036F (USD Million)
        3. Asia Pacific, 2023-2036F (USD Million)
        4. Latin America, 2023-2036F (USD Million)
        5. Middle East & Africa, 2023-2036F (USD Million)
  12. North America Liposome Drug Delivery Market
    1. Market Overview
    2. Market Size (2023-2036)
    3. Market Segmentation by:
      1. Product
        1. Liposomal Doxorubicin, 2023-2036F (USD Million)
        2. Liposomal Paclitaxel, 2023-2036F (USD Million)
        3. Liposomal Amphotericin, 2023-2036F (USD Million)
        4. Others, 2023-2036F (USD Million)
      2. Technology
        1. Stealth Liposome Technology, 2023-2036F (USD Million)
        2. Non-PEGylated Liposome Technology, 2023-2036F (USD Million)
        3. DepoFoam Liposome Technology, 2023-2036F (USD Million)
      3. Application
        1. Fungal Diseases, 2023-2036F (USD Million)
        2. Pain Management, 2023-2036F (USD Million)
        3. Cancer Therapy, 2023-2036F (USD Million)
        4. Viral Vaccines, 2023-2036F (USD Million)
        5. Photodynamic Therapy, 2023-2036F (USD Million)
        6. Others, 2023-2036F (USD Million)
      4. Country
        1. United States, 2023-2036F (USD Million)
        2. Canada, 2023-2036F (USD Million)
  13. Europe Liposome Drug Delivery Market
    1. Market Overview
    2. Market Size (2023-2036)
    3. Market Segmentation by:
      1. Product
      2. Technology
      3. Application
      4. Country
        1. Germany, 2023-2036F (USD Million)
        2. United Kingdom, 2023-2036F (USD Million)
        3. France, 2023-2036F (USD Million)
        4. Italy, 2023-2036F (USD Million)
        5. Spain, 2023-2036F (USD Million)
        6. Rest of Europe, 2023-2036F (USD Million)
  14. Asia Pacific Liposome Drug Delivery Market
    1. Market Overview
    2. Market Size (2023-2036)
    3. Market Segmentation by:
      1. Product
      2. Technology
      3. Application
      4. Country
        1. China, 2023-2036F (USD Million)
        2. India, 2023-2036F (USD Million)
        3. Japan, 2023-2036F (USD Million)
        4. Australia, 2023-2036F (USD Million)
        5. New Zealand, 2023-2036F (USD Million)
        6. Rest of APAC, 2023-2036F (USD Million)
  15. Latin America Liposome Drug Delivery Market
    1. Market Overview
    2. Market Size (2023-2036)
    3. Market Segmentation by:
      1. Product
      2. Technology
      3. Application
      4. Country
        1. Brazil, 2023-2036F (USD Million)
        2. Mexico, 2023-2036F (USD Million)
        3. Rest of LATAM, 2023-2036F (USD Million)
  16. Middle East & Africa Liposome Drug Delivery Market
    1. Market Overview
    2. Market Size (2023-2036)
    3. Market Segmentation by:
      1. Product
      2. Technology
      3. Application
      4. Country
        1. GCC, 2023-2036F (USD Million)
        2. South Africa, 2023-2036F (USD Million)
        3. Rest of MEA, 2023-2036F (USD Million)

 

Liposome Drug Delivery Market Analysis

Application (Fungal Diseases, Pain Management, Cancer Therapy, Viral Vaccines, Photodynamic Therapy)

The cancer therapy segment in the liposome drug delivery market is anticipated to hold the largest revenue share of 41% by the end of 2036. This can be attributed to the high prevalence of cancer and the growing demand for advanced therapeutics. As cancer is one of the diseases which attracts more attention from the R&D owing to its high prevalence and seriousness, this segment is anticipated to grow in the upcoming times. According to a report, there were approximately 19.3 million new cancer diagnoses worldwide in 2020, with breast cancer being the most common cancer, followed by lung cancer.

Product (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B)

The liposomal doxorubicin segment is anticipated to hold 38% share of the global liposome drug delivery market by the end of 2036. This segment includes liposomes that are used to deliver the chemotherapy drug doxorubicin. Liposomal doxorubicin is effective in treating certain types of cancer, such as ovarian and breast cancer which is further expected to contribute to the growth of the segment over the coming decades.

Our in-depth analysis of the global market includes the following segments:

          Product

  • Liposomal Doxorubicin
  • Liposomal Paclitaxel
  • Liposomal Amphotericin B

         Technology

  • Stealth
  • Non-PEGylated
  • DepoFoam Liposome Technology

         Application

  • Fungal Diseases
  • Pain Management
  • Cancer Therapy
  • Viral Vaccines
  • Photodynamic Therapy
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4073
  • Published Date: Dec 06, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of grouting materials is assessed at USD 6.4 billion.

The liposome drug delivery market size was over USD 5.97 billion in 2024 and is anticipated to cross USD 18.52 billion by 2037, growing at more than 9.1% CAGR during the forecast period i.e., between 2025-2037. The rising prevalence of cancer globally, and the increasing application of liposomes as a drug delivery system will drive the market growth.

North America industry is anticipated to dominate majority revenue share of 45% by 2037, impelled by increasing prevalence of cancer in the region.

The major players in the market are Spectrum Pharmaceuticals, Inc., Gilead Sciences, Inc., Celsion Corporation, Ipsen Pharma, Pacira Pharmaceuticals, Inc., Novartis AG, CordenPharma International, FUJIFILM Toyama Chemical Co., Ltd., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample